Redeye: Ortoma Q2 2023 - Ignition engaged
Redeye leaves its comments on Ortoma following its Q2 2023 report. Ortoma has engaged the market launch in Japan for OTS™ Hip, and the report contained a milestone payment of SEK16.9m leading to a positive EBIT margin.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/